Allelic imbalance within the E-cadherin gene is an infrequent event in prostate carcinogenesis

Genes Chromosomes and Cancer

Volumn 27, Issue 1, 2000, Pages 104-109

  Murant, Susan J ^a   Rolley, Nicky ^a   Phillips, Stewart M A ^b   Stower, Michael ^c   Maitland, Norman J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME 16; DNA POLYMORPHISM; GENE DELETION; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ALLELES; CADHERINS; CHROMOSOMES, HUMAN, PAIR 16; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; SEQUENCE DELETION;

EID: 0033990241     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200001)27:1<104::AID-GCC13>3.0.CO;2-6     Document Type: Article

References (39)

1. Al-Ghamdi AA, Sanders CM, Keefe M, Coggon D, Maitland NJ. 1995. Human papillomavirus DNA and TP53 mutations in lung cancers from butchers. Br J Cancer 72:293-297.
2. Becker K-F, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H. 1994. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54:3845-3852.
3. Becker KF, Reich U, Schott C, Höfler H. 1995. Single nucleotide polymorphisms in the human E-cadherin gene. Hum Genet 96:739-740.
4. Berx G, Staes K, Van Hengel J, Molemans F, Bussemakers MJG, van Bokhoven A, van Roy F. 1995. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26:281-289.
5. Berx G, Cleton-Jansen AM, Strumane K, De Leeuw WJF, Nollet F, van Roy F, Cornelisse C. 1996. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13:1919-1925.
6. Bussemakers MJG, van Bokhoven A, Mees SGM, Kemler R, Schalken JA. 1993. Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Reports 17:123-128.
7. Bussemakers MJG, Giroldi LA, van Bokhoven A, Schalken JA. 1994. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. Biochem Biophys Res Comm 203:1284-1290.
8. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB. 1990. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755.
9. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
10. Cui H, Horon IL, Ohlsson R, Hamilton SR, Feinberg AP. 1998. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat Med 4:1276-1280.
11. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O Vihko P. 1999. Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-16q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumor and poor prognosis for the patient. Br J Cancer 79:156-160.
12. Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB. 1995. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: Correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res 55:4813-4817.
13. Giroldi LA, Schalken JA. 1993. Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metast Rev 12:29-37.
14. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK. 1995. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803.
15. Hedrick L, Cho KR, Vogelstein B. 1993. Cell adhesion molecules as tumor suppressors. Trends Cell Biol 3:36-39.
16. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W. 1995. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11:475-484.
17. Isaacs WB, Bova GS, Morton RA, Bussemakers MJG, Brooks JD, Ewing CM. 1995. Molecular biology of prostate cancer progression. Cancer Surv 23:19-32.
18. Lakhani SR, Collins N, Stratton MR, Sloane JP. 1995. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 48:611-615.
19. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R. 1997. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res 57:1058-1062.
20. Latil A, Lidereau R. 1998. Genetic aspects of prostate cancer. Virchows Archiv 432:389-406.
21. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. 1992. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 4:16-24.
22. Macintosh CA, Stower M, Reid N, Maitland NJ. 1998. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res 58:23-28.
23. Morton RA, Ewing CM, Nagafuchi A, Tsukita S, Isaacs WB. 1993. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res 53:3585-3590.
24. Murant SJ, Handley J, Stower M, Reid N, Cussenot O, Maitland NJ. 1997. Co-ordinated changes in expression of cell adhesion molecules in prostate cancer. Eur J Cancer 33:263-271.
25. Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, Opgenorth TJ, Nelson WG, Bova GS. 1997. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 57:35-37.
26. Pan Y, Matsuyama H, Wang NN, Yoshihiros, Häggarth L, Li C, Tribukait B, Ekman P, Bergerheim USR. 1998. Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer. Prostate 36:31-38.
27. Phillips SMA, Barton CM, Lee SJ, et al. 1994a. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 70:1252-1257.
28. Phillips SMA, Morton DG, Lee SJ, Wallace DMA, Neoptolemos JP. 1994b. Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol 73:390-395.
29. Pierceall WE, Woodard AS, Morrow JS, Rimm D, Fearon ER. 1995. Frequent alterations in E-cadherin and α- and β-catenin expression in human breast cancer cell lines. Oncogene 11:1319-1326.
30. Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H. 1995. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res 55:3399-3405.
31. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. 1994. Allelotype of human ovarian cancer. Cancer Res 51:5118-5121.
32. Schalken JA, Smit F, Bringuier PP, van Bokhoven A, Wirjes F, Ebruyne FMJ, Bussemakers MJG. 1995. The role of E-cadherin mutations in bladder and prostate cancer. Urol Res 23:P57.
33. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimizaki J. 1996. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 17:225-233.
34. Takeichi M. 1993. Cadherins in cancer: implications for invasion and metastasis. Current Opin Cell Biol 5:806-811.
35. Tsuda H, Hirohashi S. 1995. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res 55:3395-3398.
36. Umbas R, Isaacs WB, Bringuier PP, et al. 1994. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 54:3929-3933.
37. Umbas R, Isaacs WB, Bringuier PP, Xue Y, Debruyne FMJ, Schalken JA. 1997. Relation between aberrant α-catenin expression and loss of E-cadherin function in prostate cancer. Int J Cancer 74:374-377.
38. Webb HD, Hawkins AL, Griffin CA. 1996. Cytogenetic abnormalities are frequent in uncultured prostate cancer cells. Cancer Genet Cytogenet 88:126-132.
39. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T, Hirohashi S. 1995. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92:7416-7419.